Jumping ahead of Merck and others, Bristol Myers declares a PD-1 first in NSCLC
Bristol Myers Squibb said this morning they cleared a PD-1 hurdle, showing for the first time that a checkpoint can clear tumors in early-stage lung …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
